Kurkunpään kroonisen tulehduksen ja syövän esiasteiden mikrobilääkehoito -tutkimusprojekti

Phase 1

• Conditions: Krooninen laryngiitti; Therapeutic area: Diseases [C] - Ear, nose and throat diseases [C09]

• Registration Number: EUCTR2020-006011-23-FI
• Lead Sponsor: Petra Pietarinen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-01-25
• Last Update Posted: 7 June 2021

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: Not specified
• Target Recruitment: 90

Inclusion Criteria

Krooninen laryngiitti ja leukoplakia
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 60
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 30

Exclusion Criteria

Antibioottiallergia ja lääkeaineinteraktion riski

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: Kurkunpäätulehduksen ja leukoplakian paraneminen;Secondary Objective: Äänen paraneminen;Primary end point(s): Laryngiitin ja leukoplakian paraneminen;Timepoint(s) of evaluation of this end point: 2, 4 ja 6 viikkoa

Secondary Outcome Measures

Name	Time	Method
Secondary end point(s): Äänen paraneminen;Timepoint(s) of evaluation of this end point: 2, 4 ja 6 viikkoa